There is immense value in clinical data (all the information captured and siloed through EHR). Pharma companies pay for access to it to gather real-world eviden

There is immense value in clinical data (all the information captured and siloed through EHR). Pharma companies pay for access to it to gather real-world evidence (RWE) how, for example, their drug performs. Molecular information is increasingly valuable too for research, biomarker development, patient cohort identification etc. The imaging data and pathology data are valuable because they are typically expertly annotated and can be used to train computer-vision algorithms etc. to solve medical problems - like diagnosis.